This study from The Journal of Translational Medicine explores how mesenchymal stem cells (MSCs) can be used to treat chronic inflammation, which is a common factor in many diseases. MSCs have special properties that allow them to reduce inflammation, repair damaged tissues, and regulate the immune system. The researchers review the latest advancements in using MSCs to treat conditions like autoimmune diseases, lung disorders, and heart problems. They also discuss challenges, such as ensuring the safety and effectiveness of these therapies. Overall, the study highlights the potential of MSC-based treatments to provide new, targeted solutions for managing inflammation and its related health issues.
Menu
